News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 on August 10, 2009

BOULDER, Colo.--(BUSINESS WIRE)--Aug. 5, 2009-- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2009 on Monday, August 10, 2009, and will hold a conference call on Tuesday, August 11, 2009 at 9:00 a.m. Eastern time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information

Date:

  Tuesday, August 11, 2009

Time:

9:00 a.m. Eastern time

Toll-Free:

888-726-2459

Toll:

913-312-0977

Pass Code:

6778402

Webcast:

www.arraybiopharma.com

 

A replay of the call will be available as a webcast on www.arraybiopharma.com and by phone for one week by dialing toll-free (888) 203-1112 or (719) 457-0820. The access code is 6778402.

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at large market opportunities. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Source: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com